What are the best treatments for Pancreatic cancer?

Treatment for pancreatic cancer is highly personalized, typically involving a combination of surgery, chemotherapy, and radiation therapy determined by the stage and location of the tumor. Because pancreatic cancer is complex, care is best managed by a multidisciplinary team to address both tumor control and symptom management.

What are the primary medical treatments for pancreatic cancer?

The standard of care for pancreatic cancer depends on whether the tumor is resectable (removable by surgery). Surgery, such as the Whipple procedure (pancreaticoduodenectomy), is the only potentially curative treatment. For patients where surgery is not an option, systemic therapies are used to slow disease progression and improve quality of life.

Which medications are commonly used?

Chemotherapy regimens for pancreatic cancer often include the following agents, which are selected based on the patient's performance status and molecular profile:

• Gemcitabine (Gemzar)


• Nab-paclitaxel (Abraxane)


• FOLFIRINOX (a combination of fluorouracil, leucovorin, irinotecan, and oxaliplatin)


• Liposomal irinotecan (Onivyde) for patients who have progressed after gemcitabine-based therapy

How does a multidisciplinary team manage the disease?

Managing pancreatic cancer requires a coordinated approach. Your care team should include:

• Surgical Oncologist: To evaluate the feasibility of tumor resection.


• Medical Oncologist: To oversee systemic chemotherapy or immunotherapy.


• Radiation Oncologist: To manage localized tumor control.


• Gastroenterologist: To manage biliary stents and digestive enzyme replacement therapy.


• Registered Dietitian: To address significant nutritional challenges and weight loss.

What are emerging treatment options?

Clinical trials for pancreatic cancer are actively investigating targeted therapies and immunotherapies. Researchers are currently studying PARP inhibitors for patients with BRCA1/2 mutations and exploring novel combinations to overcome the dense stroma that often surrounds pancreatic cancer cells. Our community of 32 members at DiseaseMaps.org encourages patients to discuss the "NCI-MATCH" trial or disease-specific registries with their oncologists.

Next steps

• Consult with a hepatobiliary surgeon to determine if you are a candidate for surgery.


• Request genetic testing (germline and somatic) to identify targeted therapy opportunities.


• Connect with the 32 members at DiseaseMaps.org to share experiences and supportive care strategies.


• Seek a referral to a palliative care specialist early in the diagnosis to manage pain and symptoms.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your oncologist for treatment decisions tailored to your clinical status.

References

• National Cancer Institute (NCI): Pancreatic Cancer Treatment (PDQ®)


• American Cancer Society: Key Statistics for Pancreatic Cancer


• Pancreatic Cancer Action Network (PanCAN) clinical trial finder


• NIH Genetic and Rare Diseases Information Center (GARD)